Clinical Trial Update: DuoTrav APS Versus XALACOM® in Ocular Surface Health [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing DuoTrav APS to XALACOM in open-angle glaucoma and ocular hypertension has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DuoTrav APS
• Xalacom (latanoprost/timolol)

Snippet

Sponsor: Alcon Research | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: TERMINATED